Ultomiris 300 mg/30mL

Ultomiris 300 mg/30mL is a pharmaceutical solution used for specific medical conditions. This intravenous concentrate is manufactured by Alexion Pharmaceuticals Inc. and is available in a 30mL vial.

Ultomiris 300 mg/30mL is a medication that contains ravulizumab, a monoclonal antibody. It is primarily used to manage certain conditions related to the complement system, which is part of the immune system. The drug is often prescribed for conditions where the complement system is overactive, leading to damage in the body. What is Ultomiris used for? It is typically used in the treatment of conditions like paroxysmal nocturnal hemoglobinuria (PNH) and atypical hemolytic uremic syndrome (aHUS).

Common effects of Ultomiris 300 mg/30mL may include infusion-related reactions such as headache, nausea, and fatigue. Some individuals might experience upper respiratory tract infection, diarrhea, and back pain. These effects can vary from person to person and are not exhaustive. Always consult a healthcare provider for personalized information.

Ultomiris 300 mg/30mL should be handled with care. It is important to follow the prescribed dosage and administration instructions provided by a healthcare professional. The solution should be stored and administered under proper medical supervision. Patients should inform their healthcare provider about any allergies or medical conditions before starting treatment.

Ultomiris 300 mg/30mL may interact with other medications, including those that affect the immune system. It is important to discuss all current medications with a healthcare provider to avoid potential interactions. Alcohol and certain foods might also interact with the drug, so it is advisable to follow medical advice regarding lifestyle adjustments during treatment.